生命科学资讯
生物技术与制药领域的最新动态
TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
Cardiff execs depart as company drops mixed Phase 2 data
UnitedHealth projects lower revenue in 2026 as it resets its business
Appointments and advancements for Jan. 27, 2026
Financings for Jan. 27, 2026
In the clinic for Jan. 27, 2026
Other news to note for Jan. 27, 2026
Regulatory actions for Jan. 27, 2026
FDA lifts hold on an Intellia CRISPR drug trial
Roche, trailing in obesity, showcases new data for GLP-1 shot
AI原生门诊手术初创公司Oath Surgical与英伟达达成合作
'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
联合治疗公司的生物工程临时肝脏在一期试验中显示出潜力。
United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
从基因疗法到……枪械？意大利生物科技公司战略转向出人意料。
From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
Lisata在收购前收回中国实体瘤候选药物权利
Lisata reclaims China rights to solid tumor candidate ahead of acquisition
患者死亡后，FDA解除对Intellia CRISPR疗法两项后期试验之一的暂停令。
After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
An immune drug developer raises $50M to finance its eczema drug testing
FDA解除对Intellia两项三期基因编辑研究之一的暂停。
FDA lifts hold on one of two Phase 3 gene editing studies by Intellia
英矽智能与齐鲁制药达成1.2亿美元心血管代谢疾病药物研发合作
Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
阿斯利康终止心血管药物研发；Lisata与齐鲁制药终止合作协议。
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal